Literature DB >> 9540171

Aerobic and anaerobic infection associated with malignancy.

I Brook1, E H Frazier.   

Abstract

The goal of this work was to study the microbiology and clinical characteristics of patients with infections associated with malignancy treated over a period of 17 years. A total of 668 specimens were obtained from 605 patients. The malignancies include 224 hematological malignancies and 381 nonhematogenic malignancies. Anaerobic bacteria only were isolated in 201 (30%) specimens, aerobic bacteria in 226 (34%), mixed aerobic-anaerobic bacteria in 231 (35%) and Candida spp. in 10 (1%). A total of 683 anaerobic (1.0 isolates per specimens) and 592 aerobic or facultative (0.9 per specimen) organisms were recovered. The predominant anaerobic bacteria included Bacteroides fragilis group isolates (181), Peptostreptococcus spp. (166), Prevotella spp. (106), Clostridium spp. (70), and Fusobacterium spp. (43). The predominant aerobic bacteria included Escherichia coli (133), Staphylococcus aureus (100), Klebsiella pneumoniae (48), and Pseudomonas aeroginosa (45). The type of infections included abscesses (221), bacteremia (198), wounds (175), including 61 cellulitis, 24 post-surgical wounds and 23 decubitus ulcers), peritonitis (48), empyema (12), cholecystitis (6) and thrombophlebitis (5). S. aureus and Peptostreptococcus spp. were isolated from all sites. However, organisms of the oropharyngeal flora (Prevotella and Fusobacterium spp.) predominated in local infections and bacteremia that originated from this site (head and neck wounds and abscesses and pulmonary infections), and organisms of the gastrointestinal tract flora predominated in infections that originated from this site (peritonitis, abdominal abscesses and decubitus ulcers). This retrospective study demonstrates polymicrobial features of many infections associated with malignancies.

Entities:  

Mesh:

Year:  1998        PMID: 9540171     DOI: 10.1007/s005200050146

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  5 in total

1.  Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period.

Authors:  Lukas Fenner; Andreas F Widmer; Clarisse Straub; Reno Frei
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

2.  Primary peritonitis in a young healthy woman: an unusual case.

Authors:  Samer Elkassem; Elijah Dixon; John Conly; Christopher Doig
Journal:  Can J Surg       Date:  2008-04       Impact factor: 2.089

3.  Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases.

Authors:  P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun
Journal:  Support Care Cancer       Date:  2003-03-13       Impact factor: 3.603

Review 4.  Lemierre's syndrome variant of the gut.

Authors:  Thomas E Mellor; Natalie Mitchell; Jessica Logan
Journal:  BMJ Case Rep       Date:  2017-10-20

Review 5.  The current spectrum of infection in cancer patients with chemotherapy related neutropenia.

Authors:  Lior Nesher; Kenneth V I Rolston
Journal:  Infection       Date:  2013-08-23       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.